HRT Financial Facts
Weighted average common shares Outstanding – basic: 2.82MGross profit: 810.76K
See Full Income Statement
Deposits, prepaid expenses and other current assets: 745.08K
Total current liabilities: 5.75M
See Full Balance Sheet
Arrhythmia Research Technology, Inc. (HRT) Earnings
|
Expand Research on HRT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/1/24 | Q224 | N/A | $0.38 | N/A | N/A | $200.65M | N/A | N/A | N/A | ||
| 5/8/24 | Q124 | N/A | $0.22 | N/A | N/A | $176.7M | N/A | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | $0.21 | N/A | N/A | $169.51M | = | N/A | N/A | ||
| 11/7/23 | Q323 | $0.36 | $0.34 | +$0.02 | $188.3M | $187.24M | = |  | | Details | |
| 8/8/23 | Q223 | $0.34 | $0.33 | +$0.01 | $192.1M | $187.81M | = | | | Details | |
| 5/9/23 | Q123 | $0.18 | $0.27 | -$0.09 | $175.4M | $172.4M | = | | | Details | |
| 3/9/23 | Q422 | $0.34 | $0.21 | +$0.13 | $175.36M | $170.4M | = | | | Details | |
| 11/17/22 | Q322 | N/A | $0.46 | N/A | N/A | $211.63M | = | N/A | N/A |
